Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis

Autor: Welty, Margaux, Mesana, Laura, Padhiar, Amie, Naessens, Dominik, Diels, Joris, van Sanden, Suzy, Pacou, Maud

Objective: To compare the relative efficacy of ustekinumab (UST) versus other therapies for 1-year response and remission rates in patients with moderate-severe UC. Methods: Randomised controlled trials reporting induction and maintenance efficacy of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf5bd455f30d5dcb5a372d67ea797bdd

Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis.

Autor: Welty M; Amaris, Health Economics and Market Access, Toronto, Canada., Mesana L; Amaris, Health Economics and Market Access, Jersey City, NJ, USA., Padhiar A; Amaris, Health Economics and Market Access, London, UK., Naessens D; Janssen Pharmaceutica NV, Beerse, Belgium., Diels J; Janssen Pharmaceutica NV, Beerse, Belgium., van Sanden S; Janssen Pharmaceutica NV, Beerse, Belgium., Pacou M; Amaris, Health Economics and Market Access, Paris, France.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2020 Apr; Vol. 36 (4), pp. 595-606. Date of Electronic Publication: 2020 Jan 29.